COMPANY

Bloom Science, Inc.

HQ: San Diego, CA source · bloomscience.com ↗ · West Coast

Bloom Science is developing oral live biotherapeutics that engage ketogenic and GABAergic pathways via the gut-brain axis, translating ketogenic biology into scalable, pharmaceutical-grade medicines. From company website Source · Oct 12, 2026

Keywords: neurology obesity Dravet syndrome amyotrophic lateral sclerosis alzheimer's disease BL-001

Location: San Diego, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)2NIH grants

Timeline

Feb 20, 2023 Trial start I: A Phase Ia Safety and Tolerability Study of BL-001 source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT05818306	A Phase Ia Safety and Tolerability Study of BL-001	I	Completed	Feb 20, 2023	May 19, 2023 (actual)

NIH awards 2

Annual award amounts. Total $510K.

Aug 11, 2025 NIH award 5R43AG087824-02 FY2025: $226,189 awarded for that fiscal year; activity R43 (SBIR); PI MIANO, ARIANNA; recipient as written: BLOOM SCIENCE, INC., SAN DIEGO, CA. Neuroprotective Engineered Bacteria for Alzhe source ↗
Sep 23, 2024 NIH award 1R43AG087824-01A1 FY2024: $283,673 awarded for that fiscal year; activity R43 (SBIR); PI MIANO, ARIANNA; recipient as written: BLOOM SCIENCE, INC., SAN DIEGO, CA. Neuroprotective Engineered Bacteria for Alz source ↗